CA2997727C - Dispositif intragastrique pour traiter l'obesite - Google Patents
Dispositif intragastrique pour traiter l'obesite Download PDFInfo
- Publication number
- CA2997727C CA2997727C CA2997727A CA2997727A CA2997727C CA 2997727 C CA2997727 C CA 2997727C CA 2997727 A CA2997727 A CA 2997727A CA 2997727 A CA2997727 A CA 2997727A CA 2997727 C CA2997727 C CA 2997727C
- Authority
- CA
- Canada
- Prior art keywords
- sleeve
- wire mesh
- openings
- point
- surface area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000008589 Obesity Diseases 0.000 title description 27
- 235000020824 obesity Nutrition 0.000 title description 20
- 210000002784 stomach Anatomy 0.000 claims abstract description 146
- 235000013305 food Nutrition 0.000 claims abstract description 128
- 210000001198 duodenum Anatomy 0.000 claims abstract description 59
- 239000012530 fluid Substances 0.000 claims abstract description 35
- 238000004891 communication Methods 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims description 38
- 238000007906 compression Methods 0.000 claims description 30
- 230000006835 compression Effects 0.000 claims description 30
- 230000033001 locomotion Effects 0.000 claims description 28
- 238000006073 displacement reaction Methods 0.000 claims description 19
- 238000013508 migration Methods 0.000 description 149
- 230000007246 mechanism Effects 0.000 description 125
- 210000001035 gastrointestinal tract Anatomy 0.000 description 100
- 210000001187 pylorus Anatomy 0.000 description 91
- 238000000034 method Methods 0.000 description 80
- 230000002496 gastric effect Effects 0.000 description 71
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 66
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 66
- 239000004810 polytetrafluoroethylene Substances 0.000 description 66
- 229910052751 metal Inorganic materials 0.000 description 58
- 239000002184 metal Substances 0.000 description 58
- 240000007817 Olea europaea Species 0.000 description 40
- 210000001519 tissue Anatomy 0.000 description 38
- 239000011248 coating agent Substances 0.000 description 34
- 238000000576 coating method Methods 0.000 description 34
- 210000000813 small intestine Anatomy 0.000 description 31
- 230000006870 function Effects 0.000 description 25
- 230000007423 decrease Effects 0.000 description 23
- 208000016261 weight loss Diseases 0.000 description 18
- 230000004580 weight loss Effects 0.000 description 18
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 16
- 229910001000 nickel titanium Inorganic materials 0.000 description 16
- 230000036186 satiety Effects 0.000 description 15
- 235000019627 satiety Nutrition 0.000 description 15
- 230000007704 transition Effects 0.000 description 15
- 238000005452 bending Methods 0.000 description 14
- 230000008901 benefit Effects 0.000 description 13
- 230000030136 gastric emptying Effects 0.000 description 12
- 230000000968 intestinal effect Effects 0.000 description 12
- 230000014759 maintenance of location Effects 0.000 description 12
- 239000003550 marker Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 230000008602 contraction Effects 0.000 description 11
- 210000000936 intestine Anatomy 0.000 description 11
- 239000012528 membrane Substances 0.000 description 11
- 229920001296 polysiloxane Polymers 0.000 description 11
- 238000012800 visualization Methods 0.000 description 11
- 229920001903 high density polyethylene Polymers 0.000 description 10
- 239000004700 high-density polyethylene Substances 0.000 description 10
- 238000007685 laparoscopic sleeve gastrectomy Methods 0.000 description 10
- 229920001684 low density polyethylene Polymers 0.000 description 10
- 239000004702 low-density polyethylene Substances 0.000 description 10
- 239000013618 particulate matter Substances 0.000 description 10
- 239000004698 Polyethylene Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 210000001630 jejunum Anatomy 0.000 description 9
- -1 polyethylene Polymers 0.000 description 9
- 229920000573 polyethylene Polymers 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 8
- 229920006240 drawn fiber Polymers 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 230000005012 migration Effects 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- 229920010741 Ultra High Molecular Weight Polyethylene (UHMWPE) Polymers 0.000 description 7
- 210000003484 anatomy Anatomy 0.000 description 7
- 238000007681 bariatric surgery Methods 0.000 description 7
- 239000011324 bead Substances 0.000 description 7
- 210000004913 chyme Anatomy 0.000 description 7
- 208000012696 congenital leptin deficiency Diseases 0.000 description 7
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- 238000011010 flushing procedure Methods 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 208000001022 morbid obesity Diseases 0.000 description 7
- 230000000472 traumatic effect Effects 0.000 description 7
- 229920001774 Perfluoroether Polymers 0.000 description 6
- 239000004696 Poly ether ether ketone Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- 230000007797 corrosion Effects 0.000 description 6
- 238000005260 corrosion Methods 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 230000002572 peristaltic effect Effects 0.000 description 6
- 229920002530 polyetherether ketone Polymers 0.000 description 6
- 230000000452 restraining effect Effects 0.000 description 6
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 5
- 206010033307 Overweight Diseases 0.000 description 5
- 238000004873 anchoring Methods 0.000 description 5
- 230000001079 digestive effect Effects 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 230000002262 irrigation Effects 0.000 description 5
- 238000003973 irrigation Methods 0.000 description 5
- 229920009441 perflouroethylene propylene Polymers 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 238000007682 sleeve gastrectomy Methods 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 4
- 206010041101 Small intestinal obstruction Diseases 0.000 description 4
- 238000009954 braiding Methods 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 229920002313 fluoropolymer Polymers 0.000 description 4
- 239000004811 fluoropolymer Substances 0.000 description 4
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000005299 abrasion Methods 0.000 description 3
- 230000010234 biliary secretion Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002183 duodenal effect Effects 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000007667 floating Methods 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000002121 nanofiber Substances 0.000 description 3
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910052715 tantalum Inorganic materials 0.000 description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 3
- 206010050456 Anastomotic leak Diseases 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 101800001586 Ghrelin Proteins 0.000 description 2
- 102000012004 Ghrelin Human genes 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004063 acid-resistant material Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 210000004141 ampulla of vater Anatomy 0.000 description 2
- 230000003872 anastomosis Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000002788 crimping Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001523 electrospinning Methods 0.000 description 2
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 235000019525 fullness Nutrition 0.000 description 2
- 238000013110 gastrectomy Methods 0.000 description 2
- 210000002599 gastric fundus Anatomy 0.000 description 2
- 210000005095 gastrointestinal system Anatomy 0.000 description 2
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 238000007683 laparoscopic Roux-en-Y gastric bypass Methods 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000008279 Dumping Syndrome Diseases 0.000 description 1
- 206010014522 Embolism venous Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 208000005489 Esophageal Perforation Diseases 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010017815 Gastric perforation Diseases 0.000 description 1
- 206010017865 Gastritis erosive Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 206010051989 Internal hernia Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010029957 Obstruction gastric Diseases 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 206010035004 Pickwickian syndrome Diseases 0.000 description 1
- 208000032395 Post gastric surgery syndrome Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 201000000660 Pyloric Stenosis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000000151 anti-reflux effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005524 ceramic coating Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003826 endocrine responses Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 208000008386 gastric outlet obstruction Diseases 0.000 description 1
- 210000001434 ghrelin secreting cell Anatomy 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000000412 mechanoreceptor Anatomy 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 235000020802 micronutrient deficiency Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 108091008709 muscle spindles Proteins 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910001453 nickel ion Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000000277 pancreatic duct Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000009118 salvage therapy Methods 0.000 description 1
- 229920000431 shape-memory polymer Polymers 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000004557 technical material Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000004043 venous thromboembolism Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037220 weight regain Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0089—Instruments for placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
- A61F5/0079—Pyloric or esophageal obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12036—Type of occlusion partial occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12163—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a string of elements connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nursing (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
L'invention concerne un dispositif intragastrique conçu pour le déploiement d'un cathéter dans un estomac comprenant des première et seconde structures en maillage métallique présentant une forme pré-déploiement qui est comprimée à l'intérieur de la lumière d'un cathéter, une forme post-déploiement ayant subi une expansion à l'intérieur de l'estomac de la personne, des ouvertures sur une partie supérieure du premier maillage, et des ouvertures sur une partie inférieure du second maillage. Le dispositif comprend également un raccord pour accoupler de manière souple une partie inférieure de la première structure à une partie supérieure de la seconde structure de sorte que les deux structures sont en communication fluidique. La nourriture entre par la partie supérieure de la première structure en maillage métallique, traverse les deux structures en maillage métallique, puis sort par la partie inférieure de la seconde structure en maillage métallique. Éventuellement, un manchon est accouplé à la partie inférieure de la seconde structure en maillage métallique et s'étend à l'intérieur du duodénum d'une personne.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/862,706 | 2015-09-23 | ||
| US14/862,706 US10420665B2 (en) | 2010-06-13 | 2015-09-23 | Intragastric device for treating obesity |
| PCT/US2016/028509 WO2017052694A1 (fr) | 2015-09-23 | 2016-04-20 | Dispositif intragastrique pour traiter l'obésité |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2997727A1 CA2997727A1 (fr) | 2017-03-30 |
| CA2997727C true CA2997727C (fr) | 2020-08-04 |
Family
ID=58387086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2997727A Active CA2997727C (fr) | 2015-09-23 | 2016-04-20 | Dispositif intragastrique pour traiter l'obesite |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3352712A4 (fr) |
| JP (1) | JP6574313B2 (fr) |
| CN (1) | CN108135719B (fr) |
| AU (3) | AU2016328478B2 (fr) |
| CA (1) | CA2997727C (fr) |
| HK (1) | HK1257683A1 (fr) |
| WO (1) | WO2017052694A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10779980B2 (en) * | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| RU179539U1 (ru) * | 2018-01-11 | 2018-05-17 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Зонд для остановки кровотечений из вен пищевода |
| US11517461B2 (en) | 2018-04-12 | 2022-12-06 | Hangzhou Tangji Medical Technology Co. Ltd | Gastric diverter and digestive tract support and release method thereof |
| US20220125434A1 (en) | 2019-01-22 | 2022-04-28 | Mayo Foundation For Medical Education And Research | Single anastomosis gastrointestinal tract bypass endoscopic systems and methods |
| US12161574B2 (en) | 2019-06-14 | 2024-12-10 | Mayo Foundation For Medical Education And Research | Methods and devices for gastricintestinal tract bypass |
| CN110664526B (zh) * | 2019-09-29 | 2021-07-20 | 上海理工大学 | 一种侧置气囊的磁控减肥胶囊 |
| CN114585332A (zh) * | 2019-11-05 | 2022-06-03 | 波士顿科学国际有限公司 | 阻隔件装置、系统和方法 |
| EP3878415A1 (fr) * | 2020-03-09 | 2021-09-15 | BariaTek Medical | Dispositif pour le traitement de l'obésité ou le diabète d'un patient et procédé de sélection d'un tel dispositif |
| EP4126177A4 (fr) * | 2020-03-23 | 2024-04-10 | Endovision Foundation | Dispositifs et procédés d'occlusion au moins partielle d'une lumière corporelle |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4607618A (en) * | 1983-02-23 | 1986-08-26 | Angelchik Jean P | Method for treatment of morbid obesity |
| US6675809B2 (en) * | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
| US6755869B2 (en) * | 2001-11-09 | 2004-06-29 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
| US7311690B2 (en) * | 2002-02-25 | 2007-12-25 | Novashunt Ag | Implantable fluid management system for the removal of excess fluid |
| DK1948075T3 (en) * | 2005-10-31 | 2016-05-09 | Reshape Medical Corp | Intragastric rumfylder |
| US8226602B2 (en) * | 2007-03-30 | 2012-07-24 | Reshape Medical, Inc. | Intragastric balloon system and therapeutic processes and products |
| CN101310692A (zh) * | 2007-05-21 | 2008-11-26 | 上海交通大学医学院附属新华医院 | 胃内减肥支架 |
| US8100932B2 (en) * | 2009-03-31 | 2012-01-24 | Onciomed, Inc. | Method and apparatus for treating obesity and controlling weight gain using self-expanding intragastric devices |
| US8403877B2 (en) * | 2009-07-01 | 2013-03-26 | E2 Llc | Systems and methods for treatment of obesity and type 2 diabetes |
| US9173734B2 (en) * | 2009-09-29 | 2015-11-03 | IBIS Medical, Inc. | Intragastric implant devices |
| US8636683B2 (en) * | 2010-01-14 | 2014-01-28 | Pavilion Medical Innovations, Llc | Systems and methods for bariatric therapy |
| US9526648B2 (en) * | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| US8628554B2 (en) * | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
| EP3329883B1 (fr) * | 2010-06-13 | 2020-07-29 | SynerZ Medical, Inc. | Dispositif intragastrique destiné à traiter l'obésité |
| US8864840B2 (en) * | 2010-10-19 | 2014-10-21 | Apollo Endosurgery, Inc. | Intragastric implants with collapsible frames |
| US9095405B2 (en) * | 2010-10-19 | 2015-08-04 | Apollo Endosurgery, Inc. | Space-filling intragastric implants with fluid flow |
| MX347374B (es) * | 2011-05-20 | 2017-04-25 | Bfkw Llc | Dispositivo y método intraluminal con anti-migración mejorada. |
| JP6175069B2 (ja) * | 2011-12-19 | 2017-08-02 | コロプラスト アクティーゼルスカブ | 内腔プロテーゼおよび胃腸インプラントデバイス |
| CN105263439B (zh) * | 2013-03-14 | 2018-11-23 | 西纳兹医疗股份有限公司 | 用于医治肥胖的胃内装置 |
| US20150196412A1 (en) * | 2014-01-15 | 2015-07-16 | Terumo Kabushiki Kaisha | Bypass device, support frame for bypass device, and method |
| CN105056404A (zh) * | 2015-09-13 | 2015-11-18 | 徐新芳 | 组合式光敷美容、减肥、理疗器 |
-
2016
- 2016-04-20 CA CA2997727A patent/CA2997727C/fr active Active
- 2016-04-20 WO PCT/US2016/028509 patent/WO2017052694A1/fr not_active Ceased
- 2016-04-20 JP JP2018534766A patent/JP6574313B2/ja not_active Expired - Fee Related
- 2016-04-20 AU AU2016328478A patent/AU2016328478B2/en not_active Ceased
- 2016-04-20 CN CN201680055465.4A patent/CN108135719B/zh active Active
- 2016-04-20 HK HK19100047.2A patent/HK1257683A1/zh unknown
- 2016-04-20 EP EP16849129.8A patent/EP3352712A4/fr not_active Withdrawn
-
2018
- 2018-12-21 AU AU2018282461A patent/AU2018282461A1/en not_active Abandoned
-
2020
- 2020-07-20 AU AU2020207787A patent/AU2020207787B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN108135719B (zh) | 2020-06-05 |
| JP2018534093A (ja) | 2018-11-22 |
| AU2018282461A1 (en) | 2019-01-24 |
| AU2016328478A1 (en) | 2018-03-22 |
| CN108135719A (zh) | 2018-06-08 |
| AU2020207787A1 (en) | 2020-08-06 |
| AU2020207787B2 (en) | 2022-06-16 |
| AU2016328478B2 (en) | 2018-09-27 |
| HK1257683A1 (zh) | 2019-10-25 |
| WO2017052694A1 (fr) | 2017-03-30 |
| JP6574313B2 (ja) | 2019-09-11 |
| EP3352712A1 (fr) | 2018-08-01 |
| EP3352712A4 (fr) | 2019-07-31 |
| CA2997727A1 (fr) | 2017-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240065869A1 (en) | Intragastric device for treating obesity | |
| AU2021218222B2 (en) | Anchorless intragastric device for treating obesity | |
| AU2020207787B2 (en) | Intragastric device for treating obesity | |
| US11135078B2 (en) | Intragastric device for treating obesity | |
| CA2962417C (fr) | Dispositif intragastrique pour traiter l'obesite | |
| JP2017534340A5 (fr) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180306 |